Influence of Danshen Injection on airway inflammation and CD4^+ CD25^+ regulatory T cells of asthmatic rats

Objective： To investigate the influence of Danshen Injection on airway inflammation and CD4^＋CD25^＋ regulatory T cells（CD4^＋CD25^＋ Tr） of asthmatic rats, and elucidate the possible mechanism of Danshen Injection in treatment of asthma. Methods： 30 Wister rats were randomly divided into control group, asthma group and Danshen Injection treated group. Bronchoalveolar lavage fluids （BALF） were collected, and cytology studies were conducted. Lung tissues were obtained and pathologic analyses were done with hematoxylin and eosin stain （HE）. Flow cytometry was used to detect the CD4^＋CD25^＋ Tr ratio in peripheral blood mononuclear cells （PBMCs）. Results： Total cell, the percentage of lymphocytes, neutrophils and eosinophils （Eos） in BALF of Danshen Injection-treated group were lower than that in asthma group （P〈0.05, P〈0.01）. Compared with asthma group, less infiltration of inflammatory cells in lung tissues was observed in Danshen Injection-treated group. CD4^＋CD25^＋ Tr of asthma group was lower than that of control and Danshen Injection treated group （P〈0.05）. Conclusion： Danshen Injection can suppress airway inflammation of asthmatic rats, probably by increasing the number of CD4^＋CD25^＋ Tr.

Pharmacokinetic parameters investigation on interaction between Danshen injection and Honghua injection

OBJECTIVE Danshen injection and Honghua injection,traditional Chinese medicine(TCM)injections,made from the extracts of Salvia miltiorrhiza Bge.and Carthamus tinctorius L.,have a potential to be developed into the useful drugs for the.As the common TCM injections,Danshen injection is often combined with Honghua injection to treat cardiovascular disease.The purpose of this study was to investigate the pharmacokinetic parameters of Honghua injection combined with Danshen injection when they were coadministered intravenously in human and rats through the tail vein.METHODS Single and multiple doses of Danshen injection to study Danshen injection on Honghua injection pharmacokinetics parameters and single and multiple doses of Honghua injection to study Honghua injection on Danshen injection pharmacokinetics parameters.The plasma concentrations of hydroxysafflor A(HSYA)and tanshinol and salvianolic acid B were determined by the reliable high-performance liquid chromatography(HPLC)method.The concentrations of HSYA in urine of rats and human were also determined by HPLC method.DAS 2.1.1software was adopted for calculating the pharmacokinetic parameters.RESULTS The simultaneous intravenous Honghua injection and salvia miltiorrhiza injiection significantly altered the pharmacokinetic parameters of both injections when compared with the individual intravenous administration of each injection.The area under the concentration-timecurve(AUC)and maximum plasma concentration(Cmax)of HSYA and tanshinol and salvianolic acid B were significantly increased.The cumulative urine excretion of HSYA in human and rats during 24 h was decreased after two drugs were administered simultaneously by the intravenous.CONCLUSION Honghua injection and Danshen injection interact with each other following simultaneous intravenous and they have a synergistic action.This experiment has identified the pharmacokinetic parameters and provided a rationale for the clinical use of the drug combination.

Effect of Salvia Miltiorrhiza Injection on Blood Pressure and Cardiac Function in Rats with Gestational Hypertension and Preeclampsia

Objective: This study is to observe the effects of Salvia miltiorrhiza injection on blood pressure and cardiac function in rats with pregnancy-induced hypertension and preeclampsia. Methodology: Syncytiotrophoblast microvilli (stbm) and l-arginine nitrosyl methyl ester were screened out via caudal vein injection. Twenty gestational hypertension-preeclampsia model SD (Sprague Dawley) rats successfully induced by L-NAME (L-arginine Nitrosyl methyl ester) were randomly divided into 2 groups (model group and Danshen injection group, n = 10). Then another 10 normal pregnant SD rats without model were selected as blank control group. The Salvia miltiorrhiza injection group was given Salvia miltiorrhiza injection (0.5 g?kg?1?d?1) through tail vein, and the control group and model group were given equal volume of normal saline through tail vein injection. All three groups were treated by tail vein injection once a day (d) for 7 days. After treatment, heart rate (HR), Systolic pressure (SP), diastolic pressure (DP) and mean arterial pressure (MAP) were measured by tail artery. Left ventricular end-diastolic diameter (LVDd) and Left ventricular end systolic diameter (LVDs) were recorded by echocardiography. Left ventricular end diastolic pressure (LVEDP), left ventricular systolic pressure (LVSP), left ventricular ejection fraction (left ventricular ejection) fraction, LVEF) and the maximum rate of increase/decrease of left ventricular pressure during isovolemic systole (+dp/dtmax/?dp/dtmax);Endothelin-1 (ET-1) levels in rat tail vein blood were detected by ELISA. Results: SP, DP, MP, HR, LVSP, LVDs and ?dp/dtmaxx were all decreased, plasma ET-1 expression was low, and LVDd, LVEDP, LVEF, and +dp/dtmax were all increased in the Salvia miltiorroot injection group, with statistical significance compared to the model group (p Conclusion: Salvia miltiorrhiza injection can improve the cardiac function and reduce blood pressure in rats with pregnancy-induced hypertension and preeclampsia, and the mechanism may be related to alleviating systemic arteriolar spasm by regulating ET-1 level.

Clinical characteristics of Danshen Ligustrazine injection in the treatment of coronary heart disease with hypertension-A real world study

Objective:To explore the characteristics and rules of Danshen Ligustrazine Injection in the treatment of coronary heart disease with hypertension.Methods:From the information systems of 12 tertiary tier-one hospitals across the country,we extracted the medical data of the application of Danshen Ligustrazine Injection in the treatment of patients with coronary heart disease and hypertension.After normalization,the model was established by Apriori algorithm,and the association rules were analyzed by Clementine 12.0 software.Results:Most of the 1928 patients were between 75 and 90 years old(54.26%).There were more males than females,most with type 2 diabetes,cerebral infarction,etc.Each dose was more than 10 mL(52.78%).Aspirin enteric-coated tablets(67.63%),L-carnitine injection(58.77%),and atorvastatin calcium capsules(50.93%)were often used in combination with safflower yellow pigment(22.20%),Shexiang Baoxin Pill(16.55%),Suxiao Jiuxin Pill(15.09%);the most commonly used combination of western medicine was anticoagulant thrombolytic and antiplatelet drugs(85.84%),and the type of Chinese medicine was Huoxuehuayu(72.98%);The most common combination of two western medicines was L-carnitine injection+aspirin enteric-coated tablets,with a support of 41.9%;The most common combination of two Chinese and western medicines is western medicine·anti-anginal medicine+western medicine·anticoagulant thrombolytic and antiplatelet drugs with a support of 67.6%.Conclusion:Danshen Ligustrazine injection is mainly used in elderly patients with coronary heart disease and hypertension,with many comorbidities.The dosage standard needs to be optimized.The combination of drugs and guidelines should coordinate with each other,which provide clues for clinical diagnosis and treatment and optimization of medication.

Effect of Compound Danshen Injection Combined with Labetalol on Liver Function and Placental Growth Factor in Patients with Eclampsia

Objective: To explore the effect of Compound Danshen Injection combined with Labetalol on liver function and placental growth factor in patients with eclampsia. Methods: Seventy patients with eclampsia who were treated in the Hospital from February 2017 to February 2019 were enrolled. The patients were divided into two groups according to the random number table, with 35 cases in each group. The Observation group was treated with Labetalol, and the combined therapy group was treated with Compound Danshen Injection combined with Labetalol. The liver function [alanine aminotransferase, aspartate aminotransferase, total protein, and albumin], hemorheology indicators, placental growth factor and serum insulin-like growth factor-1 and clinical indicators in the two groups were analyzed. Results: After treatment, the levels of alanine aminotransferase and aspartate aminotransferase in the combined therapy group were significantly lower than those in the Observation group. The levels of total protein and albumin in the combined therapy group were significantly higher than those in the Observation group (P<0.05). After treatment, the high-cut and low-cut whole blood viscosity, plasma viscosity and erythrocyte rigidity index in the combined therapy group were significantly lower than the Observation group, and the difference was statistically significant (P<0.05). After treatment, the levels of PLGF and IGF-1 in the combined therapy group were significantly higher than those in the Observation group, and the difference was statistically significant (P<0.05). After treatment, the gestational age, neonatal weight index, placental weight and neonatal 1 min Apgar score in the combined therapy group were significantly higher than the Observation group, and the difference was statistically significant (P<0.05). Conclusion: For patients with eclampsia, Compound Danshen Injection combined with Labetalol is with great safety, which can help stabilize their condition, and improve their liver function and placental growth factor status.

Efficacy of Danshen Injection Combined with Phosphocreatine Disodium in Treating Frequent Premature Contractions during Pregnancy and Its Effects on Maternal and Infant Outcomes

[Objectives]To explore the efficacy of Danshen Injection combined with phosphocreatine disodium in treating frequent premature contractions during pregnancy and its effect on maternal and infant outcomes.[Methods]A total of 200 pregnant women with normal pregnancy and frequent premature contractions who were treated in the outpatient department of internal medicine in Women and Children's Hospital of Hubei Province and Xinzhou District People's Hospital of Wuhan Central Hospital during September 2015 and October 2018 were selected and randomly divided into the control group and observation group,100 cases for each group.The observation group was treated with Danshen Injection combined with phosphocreatine disodium,and the control group was treated with phosphocreatine disodium alone.The course of treatment in both groups was one week.During the treatment,the changes of heart rate,heart rhythm,electrocardiogram and 24-h dynamic electrocardiogram(DCG)of both groups were observed.[Results]After treatment,the clinical efficacy of the observation group was better than that of the control group,and the difference was statistically significant(P<0.01).There were no adverse drug reactions in both groups.However,in the control group,non-sustained ventricular tachycardia(NSVT)was found in 24-h dynamic electrocardiogram(DCG)of 2 pregnant women with premature ventricular contraction.The pregnancy process was smooth,with full-term natural delivery and no fetal malformation.There was no significant difference in gestational age and neonatal weight between the two groups(P>0.05).However,there was a statistically significant difference in Apgar score between the two groups(P<0.05).During the 6-month postpartum follow-up,the mother and child were unharmed,and examination of repeated electrocardiograms showed that the conditions were normal.[Conclusions]Danshen Injection combined with phosphocreatine disodium has better efficacy in the treatment of frequent premature contractions during pregnancy and the maternal and infant outcomes than the treatment with phosphocreatine disodium alone,and it has good safety and can prevent premature contractions from progressing to tachyarrhythmias.

Experimental study of Danshen injection on lumbar radiculitis in rats

Objective: To investigate the therapeutic effect and mechanism of Danshen injection on lumbar radiculitis in rats. Methods: A total of 60 Wistar rats were randomly divided into normal group, model group, Danshen group, and control group, with 15 in each group. After the lumbar radiculitis model was established, the model group, the Danshen group and the control group were treated with saline, Danshen injection and Adenocobalamin injection (once a day for 2 weeks), respectively. The normal group was without any intervention. On the 1st, 7th, 14th and 30th day after the operation, the gait and tactile scores of rats were measured, and electrophysiology was measured on the 30th day. The plasma levels of β-endorphin and adrenocorticotropic hormone were measured by enzyme-linked immuno sorbent assay on the 7th,14th and 30th day. Results: Compared with the model group, the gait and tactile scores, the β-endorphin content in plasma and nerve conduction velocity of the Danshen group and the control group were increased (P<0.05), and the adrenocorticotropic hormone content was decreased (P<0.05). The Danshen group was slightly better than the control group (P<0.05). Conclusions: Danshen injection is safe and effective in the treatment of lumbar radiculitis in rats. It may play a therapeutic role by regulating the expression ofβ-endorphin and adrenocorticotropic hormone.

Effect of low-dose aspirin and Danshen injection on hemorheology, vascular endothelial function and oxidative stress in pregnancy-induced hypertension

Objective:To investigate the effect of low dose aspirin and salvia miltiorrhiza injection on hemorrheology, endothelial function and oxidative stress in patients with pregnancy induced hypertension.Methods: One hundred and eighty pregnancy-induced hypertension patients treated in our hospital from April 2015 to November 2016 were selected as study subjects and randomly divided into control group and observation group with 90 cases in each group. The control group was given routine treatment. The observation group was treated with low-dose aspirin plus Salvia miltiorrhiza in the control group. After treatment, blood rheology, vascular endothelial function and oxidative stress were measured in two groups.Results: The levels of MAP and 24 h Upro in both groups were significantly lower than those before treatment. After treatment, the MAP and 24 h Upro levels in the observation group were significantly lower than those in the control group. After treatment, the level of PT was significantly higher than that before treatment, while the level of DD and Fg was significantly lower than that before treatment. Comparing the two groups after treatment showed that the PT level, and the levels of DD and Fg were significantly lower than those in the control group;After treatment, NO levels in both groups were significantly higher than those before treatment, ET-1 and ET-1/NO levels were significantly lower than before treatment, after treatment, ET-1, NO and ET The NO level in the observation group was significantly higher than that in the control group, while ET-1 and ET-1/NO levels were significantly lower than those in the control group;Compared with those before treatment, the levels of SOD in the two groups were significantly increased and MDA significantly decreased after treatment. The SOD and MDA levels in the two groups after treatment showed that the SOD level in the observation group was significantly higher than that in the control group, while MDA level was significantly lower than that of the control group.Conclusion: The combination of low-dose aspirin and Salvia miltiorrhiza injection has significant therapeutic effect on gestational hypertension, and can effectively improve the hemorheological parameters and endothelial function of patients and reduce the oxidative stress injury in patients. It is worth further clinical promotion.

Clinical efficacy of Danshen injection in combined with local injection of triamcinolone acetonide in the treatment of oral submucous fibrosis and the effect on serum TGF-β1 and IL-6

Objective:To explore the clinical efficacy of Danshen injection in combined with local injection of triamcinolone acetonide in the treatment of oral submucous fibrosis (OSF) and the effect on serum TGF-β1 and IL-6.Methods:A total of 70 patients with OSF who were admitted in our hospital from October, 2015 to October, 2016 were included in the study and randomized into the observation group and the control group (n=35). The patients in the control group were given multipoint injection of triamcinolone acetonide (40 mg/time) in the basal region of oral mucosal regions. On this basis, the patients in the observation group were given additional Danshen injection (4 mL/time), 1 time/week, for 12 times. VAS was used for evaluation. The oral mucosa lesion area and mouth opening were measured. The morning fasting peripheral venous blood before and after treatment in the two groups was collected. The blood rheometer was used to detect the whole blood viscosity [high shear (HS), moderate shear (MS), and low shear (LS)], plasma viscosity (PV), and fibrinogen (FIB). ELISA was used to detect the serum TGF-β1 and IL-6 levels.Results: VAS score in the observation group was significantly reduced (P<0.05), mucosal lesion area was significantly less than that in the control group (P<0.05), and mouth opening was significantly greater than that in the control group (P<0.05). LS, MS, PV, and FIB after treatment in the observation group were significantly reduced when compared with before treatment (P<0.05), while LS, MS, HS, PV, and FIB after treatment in the control group were not significantly changed (P>0.05). TGF-β1 and IL-6 levels after treatment in the observation group were significantly lower than those in the control group (P<0.05).Conclusions: Danshen injection in combined with local injection of triamcinolone acetonide in the treatment of OSF can effectively reduce the serum TGF-β1 and IL-6 levels, inhibit the connective tissue fibrosis, and improve the pain, oral mucosal lesion area, and mouth opening, with a satisfactory clinical effect.

Cardioprotective effect of Danshen injectable powder on pressure overloadinduced ventricular remodeling in rats and isoproterenol induced myocardial injury in mice

OBJECTIVE To determine the effects of Danshen injectable powder on myocardial remodeling in pressure overload rats and isoproterenol(ISO) injection mice.METHODS SD Rats were subject to abdominal aortic constriction(AAC) surgery to develop pressure overload.Therapeutic effect of Danshen injectable powder was assessed six weeks after AAC surgery.The lactic dehydrogenase(LDH) and creatine kinase(CK) levels in serum,biometric,echocardiographic parameters,interstitial fibrosis,the expression of DJ-1 and SOD2 were then measured.The myocardial impairment in mice was induced by ISO injection.LDH and CK in serum,biometric,interstitial fibrosis were measured to investigate the cardioprotective effect of Danshen injectable powder.Matrix-assisted laser desorption mass spectrometry imaging(MALDI-MSI) was used to detect the changes of 60-1000 Da molecules in mice heart tissue.RESULTS In AAC rats,we observed compensatory hypertrophy and perivascular fibrosis,however cardiac function had not progressed to deterioration.The levels of LDH and CK were decreased significantly in the Danshen injectable powder groups(P<0.05,P<0.05).Danshen injectable powder could alleviate the perivascular collagen deposits but not cardiac hypertrophy in AAC rats.Furthermore,Danshen injectable powder enhanced the expression levels of SOD2 and DJ-1 in cardio.myocytes(P<0.05,P<0.01).In ISO injection mice,the levels of HWI and LDH were decreased signifi.cantly in drug treatment group compared with model group(P<0.01,P<0.01).In the MALDI-MSI of mice heart section,Danshen injectable powder can improve the reduction of energy metabolism-related substances including adenosine,creatine and ADP induced by ISO impairment.CONCLUSION Danshen injectable powder can attenuate perivascular fibrosis and improve the expression of antioxidative stress-related proteins SOD2,DJ-1 in the rats with pressure overload-induced left ventricular remodeling.Danshen injectable powder has cardioprotective effect on ISO impairment in mice which is probably related to improvement of energy metabolism.

丹参片联合那屈肝素钙注射液对髋部骨折术后下肢静脉血流参数的影响

目的探讨丹参片联合那屈肝素钙注射液对髋部骨折术后下肢静脉血流参数的影响。方法将2021年12月至2022年12月接受髋部骨折手术治疗的108例患者作为研究对象,按随机数字表法分为对照组和观察组,每组54例,2组均在术后开始用药,对照组采用那屈肝素钙注射液治疗,观察组采用丹参片联合那屈肝素钙注射液治疗,2组均治疗7 d后,对比术前及术后7 d患肢小腿直径差,对比术前及术后7 d疼痛分级(NRS)、下肢静脉血流参数(股总静脉、股浅静脉、股深静脉)、凝血酶时间(TT)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、骨碱性磷酸酶(BALP)、骨钙素(BGP)、Ⅰ型胶原羧基端交联肽(CTX-1),比较2组术后下肢静脉血栓发生率、药物不良发生率。结果观察组术前及术后7 d患肢小腿直径差明显低于对照组,NRS评分低于术前及对照组术后7 d,差异均有统计学意义(P<0.05);术后7 d观察组股总静脉、股浅静脉、股深静脉参数、TT、PT、APTT、BALP、BGP水平明显高于术前及对照组术后7天,CTX-1水平明显低于术前及对照组术后7天,差异均有统计学意义(P<0.05);2组不良反应总发生率比较,差异无统计学意义(P>0.05);观察组下肢脉血栓发生率明显低于对照组(P<0.05)。结论丹参片联合那屈肝素钙注射液用于髋部骨折术后,能缓解患者肿胀及疼痛,加快下肢静脉血流,降低患者血液高凝状态,改善骨代谢指标,进而降低血栓发生率。

基于中和医派以丹参注射液治疗肺动脉高压所致右心衰竭临床观察

目的 研究中和派思想指导下,以丹参注射液治疗肺动脉高压所致右心衰竭的临床效果。方法 收集2021年1月—2022年2月九江市第一人民医院收治的肺动脉高压伴右心衰竭患者111例,按随机数字表法分为3组,分别为对照组、西药组和联合组,每组37例;对照组采用临床常规治疗方案,西药组在对照组的基础上加用托伐普坦,联合组在西药组基础上加用丹参注射液,3组均治疗28 d,观察临床疗效及血清N末端B型利钠肽原(NT-proBNP)、β2微球蛋白(β2-MG)水平。结果联合组总有效率为94.59%(35/37)、西药组总有效率为89.19%(33/37),均显著高于对照组的78.38%(29/37)(P<0.05)。与治疗前比较,3组中医临床症状体征积分均明显降低,且治疗后联合组中医临床症状体征积分低于西药组及对照组(P<0.05)。与治疗前比较,3组患者NT-proBNP、β2-MG水平均明显降低(P<0.05),且联合组NT-proBNP、β2-MG水平明显低于西药组及对照组(P<0.05)。结论 丹参注射液联合托伐普坦治疗肺动脉高压伴右心衰竭,能够显著提高临床效果、改善临床症状、降低患者血清NT-proBNP、β2-MG水平,值得临床应用。

复方丹参注射液联合西医治疗慢性肺源性心脏病心力衰竭疗效的Meta分析

目的:系统评价复方丹参注射液联合西医治疗肺源性心脏病心力衰竭的有效性和安全性。方法:检索中国知网、万方、维普、中国生物医学文献服务系统(SinoMed)、PubMed、the Cochrane Library、EMbase等数据库建库至2022年10月1日有关复方丹参注射液联合西医治疗肺源性心脏病心力衰竭的随机对照试验(RCT)。依据纳入及排除标准筛选得到相关文献,使用RevMan 5.4和Stata 14.0对纳入研究进行Meta分析。结果:共纳入29篇文献,涉及2879例病人,其中试验组1456例,对照组1423例。试验组总有效率高于对照组[RR=1.29,95%CI(1.25,1.34),P<0.001];试验组心率减慢时间[WMD=-3.08,95%CI(-3.66,-2.51),P<0.00001]、发绀缓解时间[WMD=-2.00,95%CI(-2.72,-1.28),P<0.00001]、水肿消退时间[WMD=-2.23,95%CI(-2.51,-1.96),P<0.00001]短于对照组;试验组血流动力学指标血细胞比容[WMD=-17.36,95%CI(-29.33,-5.39),P=0.004]、全血高切黏度[WMD=-1.55,95%CI(-2.03,-1.07),P<0.00001]、全血低切黏度[WMD=-3.04,95%CI(-3.91,-2.17),P<0.001]、血浆黏度[WMD=-0.21,95%CI(-0.23,-0.19),P<0.00001]、纤维蛋白原[WMD=-0.71,95%CI(-1.03,-0.39),P<0.001]低于对照组。结论:现有证据表明,复方丹参注射液联合西医治疗肺源性心脏病心力衰竭疗效显著且安全性较好。

柴胡当归散加减联合穴位注射丹参注射液治疗乙肝肝纤维化临床观察

目的:观察柴胡当归散加减联合穴位注射丹参注射液治疗乙肝肝纤维化的临床疗效。方法:选取乙肝肝纤维化患者86例,采用随机数字表法分为两组,每组43例,对照组予恩替卡韦治疗,观察组在恩替卡韦的基础上予柴胡当归散加减配合穴位注射丹参注射液治疗。2周为1个疗程,两组均连续治疗12个疗程。对比两组疗效,于治疗前后观察两组中医症候积分、肝纤维化指标[透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原(PC-Ⅲ)、Ⅳ型胶原(Ⅳ-C)]、肝功能指标[总胆红素(TBIL)、谷丙转氨酶(ALT)、谷草转氨酶(AST)]及肝脏硬度(LSM)差异,记录并比较两组患者不良反应发生率。结果:治疗后,观察组总有效率为95.35%,较对照组的79.07%更高(P<0.05)。观察组胁肋胀痛、胸闷善太息、神疲乏力、性情急躁、脘腹痞闷、小便不利、大便溏薄症候积分低于对照组(均P<0.05)。观察组HA、LN、PC-Ⅲ、Ⅳ-C、TBIL、ALT、AST水平及LSM低于对照组(均P<0.05)。结论:采用柴胡当归散加减配合穴位注射丹参注射液治疗乙肝肝纤维化患者可提升疗效,显著改善患者肝纤维指标及肝功能,降低肝脏硬度。

杂合式血液净化序贯疗法与丹参注射液联合治疗重症急性胰腺炎的效果分析

目的分析杂合式血液净化序贯疗法与丹参注射液联合治疗重症急性胰腺炎(SAP)的效果。方法98例SAP患者,使用随机数字表法分为对照组(49例)与研究组(49例)。两组均接受基础治疗,对照组应用杂合式血液净化序贯疗法,研究组在其基础上联合丹参注射液治疗。比较两组患者的临床疗效、症状与体征改善时间、不良反应发生情况。结果研究组患者总有效率95.92%高于对照组的81.63%(P<0.05)。研究组腹痛腹胀消失时间、血尿淀粉酶恢复正常时间、尿恢复正常时间、体温恢复正常时间分别为(4.23±0.95)、(4.15±1.06)、(6.00±0.92)、(5.02±0.85)d,均短于对照组的(6.00±0.86)、(6.45±1.09)、(7.56±1.00)、(6.50±0.79)d(P<0.05)。两组不良反应发生率比较未见差异性(P>0.05)。结论杂合式血液净化序贯疗法与丹参注射液联合治疗SAP效果确切,能够促进患者症状与体征恢复,具有临床推广价值。

针刺配合穴位注射治疗颈椎病患者的临床疗效及症状改善情况

目的分析针刺配合穴位注射治疗颈椎病患者的临床疗效及症状改善情况。方法选取2020年12月—2022年12月中国人民解放军海军安庆医院收治的80例混合型颈椎病患者为观察对象,采用随机数字表法分为针刺组和穴位注射组各40例,针刺组采用针刺穴位进行治疗,穴位注射组采用针刺配合穴位注射丹参注射液进行治疗,比较两组治疗后的临床疗效、症状改善情况、颈椎活动度、血液流变学指标水平、生活质量评分,并进行安全性评价。结果治疗后,穴位注射组临床总有效率(92.50%,37/40)显著高于针刺组(75.00%,30/40)(P<0.05);两组中医证候积分均显著降低(P<0.05),颈椎整体症状积分均显著升高(P<0.05),且组间各积分差异有统计学意义(P<0.05);两组颈椎前屈、后伸、左侧屈、右侧屈活动度均显著升高(P<0.05),且穴位注射组各活动度明显高于针刺组(P<0.05);穴位注射组红细胞聚集指数、红细胞压积、血浆黏度均显著下降(P<0.05),且血浆黏度明显低于针刺组(P<0.05);两组主观症状、临床体征、适应能力评分及总分均显著升高(P<0.05),且穴位注射组分数均明显高于针刺组(P<0.05);治疗期间两组均未出现明显不良反应。结论应用针刺配合穴位注射有助于提高混合型颈椎病患者临床疗效,改善临床症状、颈椎活动度及生活质量,且可调节血液流变学状态,安全可靠,值得临床推广应用。

丹参注射液预防普外科手术后患者下肢深静脉血栓形成的疗效观察

目的 分析丹参注射液预防普外科手术后患者下肢深静脉血栓形成的疗效。方法 110例接受普外科手术的患者作为观察对象,采用信封抽签分组法分为研究组和对照组,各55例。对照组围术期采用常规手段预防下肢深静脉血栓形成,研究组围术期在对照组基础上增加丹参注射液预防下肢深静脉血栓形成。比较两组手术前后凝血功能指标[纤维蛋白原(FIB)、活化部分凝血活酶时间(APTT)以及凝血酶原时间(PT)]、血液流变学指标(全血高切粘度、全血低切粘度)、炎性因子[白细胞介素(IL-6)、C反应蛋白(CRP)]水平及下肢深静脉血栓形成发生情况。结果 研究组手术后FIB以及APTT、PT水平均优于对照组,差异有统计学意义(P<0.05)。研究组手术后全血高切粘度(3.38±0.23)mPa·s以及全血低切粘度(16.06±1.47)mPa·s均低于对照组的(4.24±0.52)、(18.72±2.84)mPa·s,差异有统计学意义(P<0.05)。研究组手术后IL-6(11.21±2.13)ng/L以及CRP(28.16±4.47)mg/L均低于对照组的(20.24±4.52)ng/L、(36.72±5.82)mg/L,差异有统计学意义(P<0.05)。研究组患者术后下肢深静脉血栓形成发生率3.64%低于对照组的16.36%,差异有统计学意义(P<0.05)。结论 丹参注射液对普外科手术后患者下肢深静脉血栓形成能起到较高的预防效果,可以改善凝血功能和血液流变学指标,促进患者更早康复。

丹参注射液联合生长抑素治疗急性胰腺炎患者的效果

目的:观察丹参注射液联合生长抑素治疗急性胰腺炎患者的效果。方法:回顾性分析2021年1月至2023年10月该院收治的80例急性胰腺炎患者的临床资料,根据治疗方法不同将其分为观察组与对照组各40例。对照组采用注射用生长抑素治疗,观察组在对照组基础上联合丹参注射液治疗。比较两组临床疗效,症状恢复情况,治疗前后疾病相关指标[人巨噬细胞趋化蛋白-1(MCP-1)、C反应蛋白(CRP)水平、血淀粉酶]水平,以及不良反应发生率。结果:观察组治疗总有效率为97.50%(39/40),高于对照组的80.00%(32/40),差异有统计学意义(P<0.05);观察组腹痛缓解时间、血淀粉酶恢复正常时间、住院时间、胃肠减压时间均短于对照组,差异有统计学意义(P<0.05);治疗后,两组MCP-1、血淀粉酶、CRP水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:丹参注射液联合生长抑素治疗急性胰腺炎患者可提高治疗总有效率,缩短症状恢复时间,降低疾病相关指标水平,其效果优于单纯生长抑素治疗。

丹参注射液联合甲基多巴在妊娠期高血压疾病患者中的应用及对其血管内皮功能与妊娠结局的影响

目的:探讨妊娠期高血压疾病(HDP)患者采用丹参注射液联合甲基多巴治疗的效果及对血管内皮功能与妊娠结局的影响。方法:选取2022年6月至2023年5月本院收治的HDP患者94例,按照随机数字表进行分组。对照组共纳入患者47例,采用甲基多巴治疗;研究组共纳入患者47例,在对照组的基础上联用丹参注射液治疗。比较两组血压值、血管内皮功能指标、不良反应与不良妊娠结局发生率。结果:两组治疗前的血压值、血管内皮功能指标对比,结果均未见显著差异(P均>0.05)。与对照组治疗14d后的结果相比,研究组收缩压、舒张压值更低(P均<0.05),内皮素-1(ET-1)指标更低(P<0.05),一氧化氮(NO)指标更高(P<0.05)。两组不良反应发生率对比,结果未见显著差异(P>0.05)。不良妊娠结局评价结果显示,与对照组19.15%相比,研究组的4.26%更低(P<0.05)。结论:丹参注射液联合甲基多巴能够降低HDP患者的血压值,改善其血管内皮功能,保障妊娠结局。